Dermatology: Diagnosis and Personalized Treatment

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".

Deadline for manuscript submissions: 25 January 2026 | Viewed by 908

Special Issue Editors


E-Mail Website
Guest Editor
Department of Dermatology, University of Medicine and Pharmacy ‘I. Hatieganu’, 400347 Cluj Napoca, Romania
Interests: dermatology; autoimmune diseases; lupus; dermato-oncology; diagnostic techniques

E-Mail Website
Guest Editor
Department of Dermatology, University of Medicine and Pharmacy ‘I. Hatieganu’, 400347 Cluj Napoca, Romania
Interests: dermatology; epidermolysis bullosa; genodermatosis; melanoma; squamous cell carcinoma
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Dermatology is the medical branch that studies the skin, dealing with the diagnosis, treatment, and prevention of diseases and disorders that affect the skin, hair, nails, and mucous membranes.

The large variety of causes and triggers behind these types of health issues represents a challenge for both clinicians and researchers: first, in finding the right diagnosis, and second, in choosing the most suitable treatment option for the patient. In this light, we value new research that refines the diagnostic process and enhances diagnostic accuracy for a tailored treatment.

Therefore, up-to-date, high-quality studies, including original research and reviews, that may offer a therapeutic approach that is personalized to the needs of the patient are welcome for submission. By contributing to this Special Issue, you will help expand the body of knowledge in dermatology and encourage the exchange of valuable insights within the scientific community.

Dr. Elisabeta Candrea
Dr. Sorina Danescu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biomarker
  • diagnostic tools
  • dermoscopy
  • ultrasound
  • confocal microscopy
  • therapeutic
  • personalized medicine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

14 pages, 3046 KB  
Review
The State of the Art in the Treatment of Actinic Keratosis and Field Cancerization: A Narrative Review
by Andrea Paradisi, Enrico Bocchino, Maria Mannino, Giulio Gualdi, Alessandra D’Amore, Daniele Omar Traini and Ketty Peris
J. Pers. Med. 2025, 15(9), 421; https://doi.org/10.3390/jpm15090421 - 3 Sep 2025
Viewed by 423
Abstract
Actinic keratosis (AK) is considered the early phase of a squamous cell carcinoma (SCC) and represents one of the most common epithelial skin lesions, with an estimated global prevalence of approximately 14%. An estimated annual risk of progression has been reported with a [...] Read more.
Actinic keratosis (AK) is considered the early phase of a squamous cell carcinoma (SCC) and represents one of the most common epithelial skin lesions, with an estimated global prevalence of approximately 14%. An estimated annual risk of progression has been reported with a range from 0 to 0.53%. Although spontaneous regression of individual AK lesions has been described in approximately 23% of cases, the frequent presence of multiple lesions, usually in the broader context of field cancerization, significantly diminishes the likelihood of regression and contributes to a higher cumulative risk of progression to SCC. The aim of the present narrative review was to provide an overview of the current evidence of the most effective available lesion-directed and field-directed treatments for actinic keratoses, on the personalized, combined, or sequential approach, as well as on the emerging therapeutic options. Full article
(This article belongs to the Special Issue Dermatology: Diagnosis and Personalized Treatment)
Show Figures

Figure 1

Back to TopTop